Your search returned 3 results.

Results
	1.	Xerophthalmia and epiphora secondary to 131I therapy in patients with differentiated thyroid cancer: a prospective study. MedStar authors: Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2017 Citation: Unpublished 2017/10/18 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman K Orquiza M Turner D Van Nostrand D Wartofsky L Wu D Local accession number: A2017_569 Add to cart (remove)
	2.	Sialoadenitis and xerostomia secondary to I-131 therapy in patients with differentiated thyroid cancer and who took sialagogues: a prospective study. MedStar authors: Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Orquiza M Turner D Van Nostrand D Wartofsky L Wu D Local accession number: A2017_576 Add to cart (remove)
	3.	Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. MedStar authors: Bethancourt, Evelyn Bikas, Athanasios Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 30361377 Year: 2019 Citation: Journal of Nuclear Medicine. 60(5):638-643, 2019 05. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.2967/jnumed.118.213256 Add to cart (remove)

Powered by Koha